Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)

Date: February 1, 2013
Pages: 43
Price:
US$ 335.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CCBA8B07CF7EN
Leaflet:

Download PDF Leaflet

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
The Competitive Intelligence Report FSH, hCG and LH: Therapeutic Proteins for Assisted Reproductive Technology (ART) as of February 2013 provides a competitor analysis in the development pipeline of novel recombinant and purified FSH, hCG and LH receptor agonists for treatment of infertility.

Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report provides information on the marketed FSH, hCG and LH preparations and includes a compilation of current active projects in research and development of novel FSH, LH and hCG receptor agonists. In addition, the report lists company-specific R&D pipelines of FSH, LH and hCG products and projects. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
  • Urinary FSH-Containing Products: Menotropins
  • Recombinant Menotropins
  • 1st Generation Purified Human Urinary FSH
  • 2nd Generation Recombinant Human FSH
  • Biosimilar Recombinant Human FSH
  • 2nd Generation Rhu FSH in Non-Regulated Markets
  • 3rd Generation Rhu FSH
  • Purified Urinary Human Choriogonadotropin (hCG)
  • Recombinant Human Choriogonadotropin (rhCG)
  • Recombinant Human Luteinizing Hormone (rhLH)
  • hCG Receptor Agonist
  • Corporate FSH, LH and hCG Product Portfolios and R&D Pipelines
Skip to top


Ask Your Question

Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: